LOR antibody (N-Term)

Catalog No. ABIN629750

Product Details anti-LOR Antibody

Target: LOR (Loricrin (LOR))

Binding Specificity: N-Term

Reactivity: Please inquire

Host: Rabbit

Clonality: Polyclonal

Conjugate: This LOR antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Specificity: Loricrin antibody was raised against the N terminal of LOR

Purification: Purified

Immunogen: Loricrin antibody was raised using the N terminal of LOR corresponding to a region with amino acids GYSGGGCGGGSSGGGGGGGIGGCGGGSGGSVKYSGGGGSSGGGSGCFSSG

Application Details

Application Notes: WB: 5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

Loricrin Blocking Peptide, catalog no. 33R-3685, is also available for use as a blocking control in assays to test for specificity of this Loricrin antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LOR antibody in PBS

Concentration: Lot specific

Buffer: PBS

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Target Details for LOR

Target: LOR (Loricrin (LOR))

Alternative Name: Loricrin (LOR Products)

Target Type: Chemical

Background: LOR is a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in this gene are associated with Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.LOR encodes loricrin, a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in LOR may be the cause of both Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.

Molecular Weight: 35 kDa (MW of target protein)